phorbol 12,13-dibutyrate has been researched along with Leukemia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goodwin, BJ; Misukonis, MA; Weinberg, JB | 1 |
| Hamada, K; Hirano, T; Nakamura, H; Oda, T; Shimizu, N; Utiyama, H | 1 |
| Hatake, K; Hayasawa, H; Horiuchi, T; Ikeda, K; Ikeda, M; Inoue, R; Ishizaka, Y; Itoh, T; Matsumoto, M; Mishima, Y; Mori, M; Niho, Y; Ozawa, K; Terui, Y; Tomizuka, H; Ueda, M; Uwai, M; Yamada, M | 1 |
| Chuang, LF; Chuang, RY; Israel, M; Kung, HF | 1 |
| Farley, BA; Giuliano, R; LaBella, S; Leary, JF; Rowley, PT | 1 |
| Brunsing, D; Hensel, G; Krönke, M; Meichle, A; Schütze, S | 1 |
| Folks, TM; Griffin, GE; Kunkel, S; Leung, K; Nabel, GJ | 1 |
| Chuang, LF; Chuang, RY; Israel, M; Zhao, FK | 1 |
| Hidaka, H; Ido, M; Kamiya, H; Sakurai, M; Sato, K | 1 |
9 other study(ies) available for phorbol 12,13-dibutyrate and Leukemia
| Article | Year |
|---|---|
Human leukemia cell lines with comparable receptor binding characteristics but different phenotypic responses to phorbol diesters.
Topics: Caenorhabditis elegans Proteins; Carcinogens; Carrier Proteins; Cell Adhesion; Cell Aggregation; Cell Line; Humans; Kinetics; Leukemia; Phenotype; Phorbol 12,13-Dibutyrate; Phorbol Esters; Phorbols; Protein Kinase C; Receptors, Cell Surface; Receptors, Drug | 1984 |
Involvement of Mac-1-mediated adherence and sphingosine 1-phosphate in survival of phorbol ester-treated U937 cells.
Topics: Apoptosis; CD18 Antigens; Cell Adhesion; Cell Survival; Humans; Integrins; Leukemia; Lysophospholipids; Macrophage-1 Antigen; Monocytes; Phorbol 12,13-Dibutyrate; Sphingosine; Tumor Cells, Cultured | 1998 |
A new apoptotic pathway for the complement factor B-derived fragment Bb.
Topics: Antibodies, Monoclonal; Apoptosis; Blotting, Western; Complement C3; Complement C3 Convertase, Alternative Pathway; Complement C3b; Dose-Response Relationship, Drug; Fas Ligand Protein; fas Receptor; Gene Expression; HL-60 Cells; Humans; Integrin alphaXbeta2; Leukemia; Lymphoma; Membrane Glycoproteins; Peptide Fragments; Phorbol 12,13-Dibutyrate; Receptors, Complement; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |
Activation of human leukemia protein kinase C by tumor promoters and its inhibition by N-trifluoroacetyladriamycin-14-valerate (AD 32).
Topics: Binding, Competitive; Cell Membrane; Doxorubicin; Drug Interactions; Enzyme Activation; Humans; Kinetics; Leukemia; Phorbol 12,13-Dibutyrate; Phosphorylation; Protein Binding; Protein Kinase C; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1992 |
Single K562 human leukemia cells express and are inducible for both erythroid and megakaryocytic antigens.
Topics: Antigens, Differentiation; Butyrates; Butyric Acid; Erythrocytes; Flow Cytometry; Glycophorins; Hematopoietic Stem Cells; Humans; Hypoxanthine; Hypoxanthines; Leukemia; Megakaryocytes; Phorbol 12,13-Dibutyrate; Thymidine; Tumor Cells, Cultured | 1992 |
Protein kinase C-independent activation of nuclear factor kappa B by tumor necrosis factor.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Base Sequence; Binding Sites; Cell Line; DNA-Binding Proteins; DNA, Viral; Down-Regulation; Enhancer Elements, Genetic; Enzyme Activation; H-2 Antigens; HIV-1; Humans; Isoquinolines; Leukemia; Molecular Sequence Data; NF-kappa B; Phorbol 12,13-Dibutyrate; Piperazines; Promoter Regions, Genetic; Protein Kinase C; Recombinant Proteins; Staurosporine; Tetradecanoylphorbol Acetate; Transcription Factors; Tumor Necrosis Factor-alpha | 1990 |
Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B.
Topics: Cell Differentiation; Chloramphenicol O-Acetyltransferase; DNA, Viral; Enhancer Elements, Genetic; Gene Expression Regulation; HIV; Leukemia; Monocytes; NF-kappa B; Phorbol 12,13-Dibutyrate; Plasmids; Tetradecanoylphorbol Acetate; Transcription Factors; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1989 |
Cremophor EL, a widely used parenteral vehicle, is a potent inhibitor of protein kinase C.
Topics: Binding, Competitive; Cell Line; DNA Polymerase II; Drug Carriers; Glycerol; Humans; Kinetics; Leukemia; Phorbol 12,13-Dibutyrate; Protein Binding; Protein Kinase C; Protein Kinases; RNA Polymerase II; Solvents; Tetradecanoylphorbol Acetate | 1989 |
Phorbol esters potentiate glucocorticoid-induced cytotoxicity in CEM-C7 human T-leukemia cell line.
Topics: Binding, Competitive; Caenorhabditis elegans Proteins; Carrier Proteins; Cell Line; Cell Survival; Dexamethasone; Drug Synergism; Growth Inhibitors; Humans; Leukemia; Phorbol 12,13-Dibutyrate; Phorbol Esters; Protein Kinase C; Receptors, Drug; Receptors, Glucocorticoid; Structure-Activity Relationship; T-Lymphocytes | 1988 |